DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Kubitza D, Becka M, Mueck W , et al.
Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor.
Br J Clin Pharmacol 2010;
70 (5) 703-712
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.